Delta-8 Side Effects: What to Expect

Delta-8-tetrahydrocannabinol (delta-8 or “D8”) produces milder versions of the same side effects as delta-9 THC: dry mouth, red eyes, drowsiness, increased appetite, and — at higher doses or in sensitive users — anxiety, paranoia, and nausea. Most effects resolve within 4–8 hours.

Delta-8 is often described as “diet weed” — a milder, hemp-derived cousin of delta-9 THC that produces a softer high with fewer reports of anxiety. That description is roughly accurate, but it can be misleading. Delta-8 is a real psychoactive cannabinoid with a real side-effect profile, and the lack of regulation in the hemp-derived market means the bigger risk is often what’s in the product, not the molecule itself. This is what to expect, who shouldn’t use it, and when to call for help.

Common side effects

The most frequently reported side effects of delta-8, in roughly the order people report them:

• Dry mouth (“cottonmouth”). Cannabinoid receptors are present in salivary glands; activating them reduces saliva production. The most universal and least dangerous side effect.
• Red, dry eyes. Cannabinoids dilate ocular blood vessels and reduce tear production. Cosmetic, mostly. Eye drops handle it.
• Drowsiness. Especially with indica-leaning chemovars or high doses. Some users report a “couch-lock” effect where moving feels like work.
• Increased appetite. Same “munchies” effect as delta-9, sometimes slightly less intense.
• Mild dizziness or lightheadedness. Common in first-time or upright-while-using situations. Sit down, hydrate, wait it out.
• Slowed reaction time and impaired coordination. Don’t drive. Don’t operate machinery. Reaction-time impairment is comparable to delta-9 even when the subjective high feels milder.

These effects come on within minutes (inhaled) or 30–90 minutes (edibles) and typically resolve within 4–8 hours from peak — longer for edibles, longer in older users, longer at high doses.

Less common side effects

Less frequent but still well-documented:

• Anxiety or paranoia. Less common than with delta-9, but real. Higher doses, novel users, or users with anxiety histories report these most. The same “I think I’m dying” panic-spiral seen with overdosing on edibles is possible with delta-8.
• Nausea or vomiting. Sometimes from the cannabinoid itself at high doses; sometimes from the carrier oils in poorly-made vape products.
• Headache. Mild, common, usually transient. Persistent headaches with regular use can indicate cannabinoid hyperemesis syndrome, which is rare but serious.
• Loss of coordination beyond mild. Not a “fun” intoxication phenomenon but a real motor impairment. Don’t combine with stairs, alcohol, or sharp objects.
• Paranoid ideation. Some users describe persistent paranoia for hours, especially with high-dose edibles. Stay in a safe environment, hydrate, sleep it off.

Acute risk: contamination

This is where delta-8 differs meaningfully from medical-grade delta-9 products. Delta-8 doesn’t occur in cannabis in significant quantities — most commercial delta-8 is synthesized from CBD through an acid-catalyzed isomerization. Done in a clean facility with proper purification, the result is fine. Done in a basement lab, it can leave behind:

• Residual reaction solvents (toluene, hexane, dichloromethane)
• Reaction byproducts — minor isomers like delta-7 and delta-10, plus a long tail of unidentified compounds depending on the synthesis route
• Acid catalyst residue from incomplete neutralization
• Heavy metals from low-grade reaction vessels

The FDA issued consumer warnings about delta-8 in 2021 and continues to track adverse-event reports. CDC and AAPCC (American Association of Poison Control Centers) data show delta-8 calls to poison control rose sharply between 2020 and 2022, with a meaningful share involving children and a small but notable number involving products contaminated with heavy metals or unspecified solvents.

The mitigation: only buy delta-8 from brands that publish current third-party Certificates of Analysis covering pesticides, heavy metals, residual solvents, and microbials — the same panel you’d want on any cannabis product.

Long-term effects: what we don’t know

This is the honest answer no one likes: we don’t have long-term human data on delta-8.

Most cannabinoid research is on delta-9 THC and CBD. Delta-8 was a research curiosity for decades and only became a mass-market product after the 2018 Farm Bill created the hemp loophole. There are no longitudinal cohorts. We don’t have multi-year safety data on synthesis byproduct exposure. We don’t have data on adolescent brain development with delta-8 specifically.

What we can extrapolate from delta-9 research (Volkow et al. 2014 NEJM review on adverse health effects of cannabis) probably applies in milder form: regular heavy use during adolescence may affect cognitive development, regular high-dose use can produce dependence in a subset of users, and chronic use is associated with respiratory issues when smoked. None of this is unique to delta-8, but none of it has been validated for delta-8 either.

Who should avoid delta-8

These categories are based on cannabinoid pharmacology generally — they apply to delta-8, delta-9, HHC, THCP, and decarbed THCA more or less equivalently:

• People who are pregnant or trying to conceive. Cannabinoids cross the placenta and the developmental data is concerning enough to make this a clear no.
• Lactating people. Cannabinoids transfer into breast milk in measurable amounts.
• People with a personal or family history of schizophrenia or other psychotic disorders. Cannabinoid use is associated with earlier onset and more severe presentations in genetically susceptible individuals.
• People with significant cardiovascular conditions. Acute cannabinoid use raises heart rate (often 20–50 bpm above baseline) and can trigger arrhythmias in vulnerable users. Several FDA case reports involve cardiac events in young users with no prior history.
• Minors (under 21). Federal law prohibits sale to anyone under 21 for hemp-derived intoxicants in most states. Beyond legality, adolescent neurodevelopment is a real concern.
• Anyone driving, flying, or operating heavy machinery. Reaction-time impairment is real even when the subjective high feels mild.

If any of these apply, abstain. If you’re managing a chronic medical condition or taking prescription medications, talk to your prescribing physician before adding delta-8 to the mix.

Drug interactions

Delta-8, like delta-9, is metabolized through the liver’s CYP450 enzyme system — primarily CYP2C9 and CYP3A4. That makes it potentially interactive with a long list of common prescription drugs:

• Blood thinners (warfarin, especially) — cannabinoids can elevate plasma concentration
• SSRIs and other antidepressants — additive sedation and rare serotonergic interactions
• Benzodiazepines and opioids — additive central nervous system depression; mixing increases overdose risk
• Statins — shared CYP3A4 metabolism may elevate plasma statin levels
• Some antiseizure medications — variable effects, both directions

The FDA’s drug interaction database lists CYP3A4 substrates if you want to check a specific medication. The general advice is: if you take any prescription medication regularly, ask your doctor before starting delta-8.

How delta-8 compares to other cannabinoids

• vs. delta-9 THC: Generally reported as milder — perhaps 60–70% of the subjective potency of delta-9, with fewer anxiety reports. Same metabolic pathway, same drug-test result, same impairment profile.
• vs. THCA flower: THCA becomes delta-9 when decarbed, so once heated they behave nearly identically. Pre-heating, raw THCA is non-psychoactive — see does THCA get you high.
• vs. CBD: CBD is non-intoxicating. Different cannabinoid, different receptor activity. Delta-8 is psychoactive; CBD generally isn’t.
• vs. HHC, THCP, delta-10: All hemp-derived intoxicants synthesized from CBD or other precursors. Side-effect profiles broadly similar; potency varies (THCP is much stronger; HHC roughly comparable to D8; delta-10 milder).

For a head-to-head, see our THCA vs delta-8 comparison.

How to minimize side effects

Practical guidance, from least to most important:

1. Verified COA brands only. Single biggest risk reducer. The contaminated-product cases are mostly buying from unknown brands at gas stations.
2. Start low, go slow. First-time dose: 5 mg edible or one or two short hits of inhaled. Wait the full onset window before re-dosing — 90+ minutes for edibles, 15 minutes for inhalation. See our dosage guide for the math.
3. Don’t combine with alcohol. Compounds the impairment, dramatically increases nausea risk, and the “spinning room” feeling people associate with edible overdoses is usually a co-ingestion problem.
4. Stay hydrated. Reduces dry mouth and headache.
5. Have an exit plan. Be in a comfortable environment with someone sober nearby if it’s your first time.
6. Don’t drive. This applies for the duration of any noticeable effect — typically 4–8 hours, longer for edibles.

When to seek medical care

Most delta-8 side effects resolve on their own within hours. Seek emergency care for:

• Severe panic that doesn’t subside in 1–2 hours, especially with chest pain or shortness of breath
• Vomiting that won’t stop (risk of dehydration, especially in elderly or pediatric users)
• Loss of consciousness, even briefly
• Cardiac symptoms — chest pain, racing heart with no recovery, fainting
• Pediatric exposure — any unintended ingestion by a child, regardless of how they seem to be doing

For non-emergency concerns or unintentional ingestion: Poison Control: 1-800-222-1222 (United States, 24/7, free, confidential).

Frequently asked questions

Related reading

• How long does delta-8 stay in your system? — detection windows
• What is delta-8? — primer
• How to read a COA — avoiding contaminated product
• Dosage guide — start-low-go-slow math
• Decarboxylation explained — why heated THCA behaves like other THCs
• Does THCA get you high? — adjacent cannabinoid effects

Educational only — not medical advice. 21+ only.

If you or someone you know has had an adverse reaction or unintentional exposure: Poison Control 1-800-222-1222 (US).

Sources: FDA, “5 Things to Know about Delta-8 Tetrahydrocannabinol” (2021, updated 2022); CDC Health Alert Network “Increases in Availability of Cannabis Products Containing Delta-8” (2021); American Association of Poison Control Centers data; Volkow ND et al. “Adverse Health Effects of Marijuana Use,” NEJM (2014); Hollister LE, “Cannabis,” Handbook of Experimental Pharmacology (1986). Last reviewed April 28, 2026.